Protego Biopharma is advancing a small-molecule drug that helps light chain proteins fold correctly, in turn addressing the underlying biological cause of AL amyloidosis.

We have long struggled to determine how the first living organisms on Earth came together. Now, surprising evidence hints that poorly understood prions may have been the vital missing ingredient ...

Protego Biopharma, Inc., a clinical-stage biotechnology company dedicated to pioneering first-in-class small molecule therapeutics that reprogram protein folding to address systemic amyloid diseases ...

Protego Biopharma is gearing up to bring its amyloid light-chain (AL) amyloidosis prospect into pivotal testing using its new ...

Eggs aren't boring. They're the opposite of boring. The secret is what you pair them with. Simple combinations of eggs with ...

Strategic Revenue Insights Inc. - The global landscape of advanced therapeutics is undergoing one of its most transformative phases, led by ...

Buyers of Bednar’s new Neveon fertiliser injection toolbar could be rewarded with some serious nitrogen efficiency gains, the company says. Like other ...

Forget lettuce, tomato, and tartar sauce. Pair your salmon burgers with these toppings instead. Think about texture and ...

CerraCap Ventures and Impact Venture Capital today announced their merger to form CerraCap Impact Venture Capital (CIVC), creating one of the most globally connected venture platforms in the industry.

A Johns Hopkins Medicine study involving a dozen people with the inflammatory skin disease hidradenitis suppurativa (HS), ...

Look past the top deals for deep savings and special finds Not every deal ends up on the front page on Cyber Monday, but we ...

On Monday, she will be inducted into a special sisterhood, Polytechnique Montréal’s Order of the White Rose, which offers a ...